Security key
88338N107
- Security type / class
- Equity / COM
- Total 13F shares
- 192,502,060
- Total 13F value
- $466,882,212
- Share change
- +19,864,255
- Put/Call ratio
- 88%
- SEC-reported price per share
- $2.42
- Number of holders
- 162
- Value change
- +$46,177,594
- Number of buys
- 83
- Number of sells
- 48
Open additional details 1 more signal available
Report period
Q4 2019
Institutions
162
Top holders
10
TXMD full security history
Ownership snapshot
Full 13F holder table
TherapeuticsMD, Inc. SEC filings
TherapeuticsMD, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TXMD - THERAPEUTICSMD INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JPMORGAN CHASE & CO
Disclosed value leader
JPMORGAN CHASE & CO
Comparable rows
0/15
Latest evidence
30 Sep 2019
13F
Highest disclosed value: $72,274,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
JPMORGAN CHASE & CO has the largest disclosed position value at $72.27M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JPMORGAN CHASE & CO's linked filing trail.
Disclosed position value
Top 5
JPMORGAN CHASE & CO
$72.27M
FMR LLC
$67.59M
BlackRock Finance, Inc.
$59.96M
Bank of New York Mellon Corp
$56.21M
PRICE T ROWE ASSOCIATES INC /MD/
$55.55M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO |
13F
Company
|
—
class O/S missing
|
$72,274,000
19,910,296 shares
|
— | 30 Sep 2019 |
| FMR LLC |
13F
Company
|
—
class O/S missing
|
$67,594,000
18,620,930 shares
|
— | 30 Sep 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$59,963,000
16,518,688 shares
|
— | 30 Sep 2019 |
| Bank of New York Mellon Corp |
13F
Company
|
—
class O/S missing
|
$56,212,000
15,485,489 shares
|
— | 30 Sep 2019 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
—
class O/S missing
|
$55,554,000
15,304,004 shares
|
— | 30 Sep 2019 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$53,069,000
14,619,657 shares
|
— | 30 Sep 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
162
Shares
192,502,060
Rows available
162
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
145
Q4 2019 holders
162
Holder diff
17
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 value | Q4 2019 value | Value change | Value Chg % |
|---|